BUSINESS
Cipla surges on receiving USFDA nod to market Lanreotide injection in US
Cipla is currently trading at Rs. 875.25, up by 16.80 points or 1.95% from its previous closing of Rs. 859.85 on the…
cipla
BUSINESS
Cipla to donate 5,000 nebulisers to primary health care centres in India
Cipla is planning to donate 5,000 nebulisers to primary health care centres in India as part of its initiative to improve access…
BUSINESS
Cipla selected in S&P Dow Jones Sustainability Index for Emerging Markets for 2021
Cipla has been selected in the S&P Dow Jones Sustainability Index (DJSI) for the Emerging Markets for 2021. The DJSI family of…
BUSINESS
Cipla gains on receiving USFDA’s final approval for Sumatriptan Nasal Spray
Cipla is currently trading at Rs. 800.10, up by 10.60 points or 1.34% from its previous closing of Rs. 789.50 on the…
BUSINESS
Cipla gains on reporting 2-fold jump in Q3 consolidated net profit
Cipla is currently trading at Rs. 807.40, up by 1.85 points or 0.23% from its previous closing of Rs. 805.55 on the…
BUSINESS
Cipla gets approval from USFDA for Valganciclovir Tablets
Cipla has received final approval for its Abbreviated New Drug Application (ANDA) for Valganciclovir Tablets 450mg from the United States Food and…
BUSINESS
Cipla’s arm acquires entire stake in Mirren
Cipla’s wholly owned subsidiary — Cipla Medpro South Africa (Pty) has completed the acquisition of 100% stake in Mirren (Pty) on October…